[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334691-105":59,"doc-detail-334691-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","efficacy-of-radiofrequency-ablation-combined-with-sorafenib-for-treating-liver-cancer-complicated-with-portal-hypertension-retrospective-study","Efficacy of radiofrequency ablation combined with sorafenib for treating liver cancer complicated with portal hypertension - Retrospective Study","","Patients with liver cancer complicated by portal hypertension face complex therapeutic challenges affecting liver function and long-term outcomes. This retrospective study assessed whether radiofrequency ablation combined with sorafenib improves clinical efficacy, biomarkers, portal hypertension parameters, adverse reactions, and survival compared with radiofrequency ablation alone. Data from 100 patients treated between May 2014 and March 2019 were analyzed, with short-term response and 3-year survival evaluated alongside multivariate logistic regression of prognostic factors.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/efficacy-of-radiofrequency-ablation-combined-with-sorafenib-for-treating-liver-cancer-complicated-with-portal-hypertension-retrospective-study/334691/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/efficacy-of-radiofrequency-ablation-combined-with-sorafenib-for-treating-liver-cancer-complicated-with-portal-hypertension-retrospective-study/334691.png","ImageObject",300,407,{"name":92,"@type":93},"Ava Thompson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the study aim regarding radiofrequency ablation and sorafenib?","Question",{"text":112,"@type":113},"To evaluate the efficacy of radiofrequency ablation combined with sorafenib for improving liver function and its impact on prognosis in liver cancer complicated by portal hypertension.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were patients grouped in the methods?",{"text":117,"@type":113},"One hundred patients were divided into a study group (n=50) receiving radiofrequency ablation plus sorafenib and a control group (n=50) receiving radiofrequency ablation alone.",{"name":119,"@type":110,"acceptedAnswer":120},"What factors were identified as independent risk factors for poor prognosis?",{"text":121,"@type":113},"High Child-Pugh grade, tumor size (6–10 cm), history of hepatitis, no use of sorafenib, liver cancer stage IIIC, and prior splenectomy were independent risk factors based on multivariate logistic regression.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334691,1790013056,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},1649267921044,"https://us-avatar.wpscdn.com/avatar/1800007509477c92dfb?_k=1786009248482753345","| W | J | G | World Journal of\u003Cbr>Gastroenterology |\n| --- | --- | --- | --- |\n\nSubmit a Manuscript: [https://www.f6publishing.com](https://www.f6publishing.com) World J Gastroenterol 2024 March 21; 30(11): 1533-1544  \nDOI: 10.3748/wjg.v30.i11.1533 ISSN 1007-9327 (print) ISSN 2219-2840 (online)  \nORIGINAL ARTICLE  \nRetrospective Study  \nEfficacy of radiofrequency ablation combined with sorafenib for treating liver cancer complicated with portal hypertension and prognostic factors  \nLi-Min Yang, Hong-Juan Wang, Shan-Lin Li, Guan-Hua Gan, Wen-Wen Deng, Yong-Sheng Chang, Lian-Feng Zhang  \nSpecialty type: Gastroenterology and hepatology  \nProvenance and peer review:  \nUnsolicited article; Externally peer reviewed.  \nPeer-review model: Single blind  \nPeer-review report’s scientific quality classification  \nGrade A (Excellent): 0  \nGrade B (Very good): B, B  \nGrade C (Good): 0  \nGrade D (Fair): 0  \nGrade E (Poor): 0  \nP-Reviewer: Moore LW, United States; Mroweh M, France  \nReceived: January 5, 2024  \nPeer-review started: January 5, 2024  \nFirst decision: January 23, 2024  \nRevised: February 18, 2024  \nAccepted: March 8, 2024  \nArticle in press: March 8, 2024  \nPublished online: March 21, 2024  \nLi-Min Yang, Hong-Juan Wang, Guan-Hua Gan, Wen-Wen Deng, Lian-Feng Zhang, Department of Gastroenterology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan Province, China  \nShan-Lin Li, Department of Gastroenterology, Zhoukou Central Hospital of Henan Province, Zhoukou 466000, Henan Province, China  \nYong-Sheng Chang, Department of Gastroenterology, The First Affiliated Hospital of Xinxiang Medical College, Xinxiang 453000, Henan Province, China  \nCorresponding author: Li-Min Yang, MD, Associate Chief Physician, Department of Gastroenterology, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Erqi District, Zhengzhou 450052, Henan Province, [China.](China. ylmsunny6153@126.com)[ ylmsunny6153@126.com](China. ylmsunny6153@126.com)  \nAbstract  \nBACKGROUND  \nPatients with liver cancer complicated by portal hypertension present complex challenges in treatment.  \nAIM  \nTo evaluate the efficacy of radiofrequency ablation in combination with sorafenib for improving liver function and its impact on the prognosis of patients with this condition.  \nMETHODS  \nData from 100 patients with liver cancer complicated with portal hypertension from May 2014 to March 2019 were analyzed and divided into a study group (n = 50) and a control group (n = 50) according to the treatment regimen. The research group received radiofrequency ablation (RFA) in combination with sorafenib, and the control group only received RFA. The short-term efficacy of both the research and control groups was observed. Liver function and portal hypertension were compared before and after treatment. Alpha-fetoprotein (AFP), glypican-3 (GPC- 3), and AFP-L3 levels were compared between the two groups prior to and after treatment. The occurrence of adverse reactions in both groups was observed. The 3-year survival rate was compared between the two groups. Basic data were  \n WJG  [https://www.wjgnet.com](https://www.wjgnet.com) 1533 March 21, 2024  Volume 30  Issue 11   \nYang LM et al. Treatment of hepatocellular carcinoma  \ncompared between the survival and non-surviving groups. To identify the independent risk factors for poor prognosis in patients with liver cancer complicated by portal hypertension, multivariate logistic regression analysis was employed.  \nRESULTS  \nWhen comparing the two groups, the research group's total effective rate (82.00%) was significantly greater than that of the control group (56.00%; P \u003C 0.05) . Following treatment, alanine aminotransferase and aspartate aminotransferase levels increased, and portal vein pressure decreased in both groups. The degree of improvement for every index was substantially greater in the research group than in the control group (P \u003C 0.05) . Following treatment, the AFP, GPC-3, an","cbCaidUBwl9TdQQW","https://ap.wps.com/l/cbCaidUBwl9TdQQW","pdf",838762,13,"English","# Abstract\n## Background\n## Aim\n## Methods\n## Results\n## Conclusion","[{\"question\":\"What is the study aim regarding radiofrequency ablation and sorafenib?\",\"answer\":\"To evaluate the efficacy of radiofrequency ablation combined with sorafenib for improving liver function and its impact on prognosis in liver cancer complicated by portal hypertension.\"},{\"question\":\"How were patients grouped in the methods?\",\"answer\":\"One hundred patients were divided into a study group (n=50) receiving radiofrequency ablation plus sorafenib and a control group (n=50) receiving radiofrequency ablation alone.\"},{\"question\":\"What factors were identified as independent risk factors for poor prognosis?\",\"answer\":\"High Child-Pugh grade, tumor size (6–10 cm), history of hepatitis, no use of sorafenib, liver cancer stage IIIC, and prior splenectomy were independent risk factors based on multivariate logistic regression.\"}]","Efficacy of radiofrequency ablation combined with sorafenib for treating liver cancer complicated with portal hypertension - Retrospective Study | PDF",1790007892,33]